Prostate-Specific Membrane Antigen Targeted Imaging and Therapy of Prostate Cancer Using a PSMA Inhibitor as a Homing Ligand-Reference-Cited by-同舟云学术

Prostate-Specific Membrane Antigen Targeted Imaging and Therapy of Prostate Cancer Using a PSMA Inhibitor as a Homing Ligand

Published:2009-05-08 Issue:3 Volume:6 Page:780-789
ISSN:1543-8384
Container-title:Molecular Pharmaceutics
language:en
Short-container-title:Mol. Pharmaceutics

Author:

Kularatne Sumith A.¹,Wang Kevin¹,Santhapuram Hari-Krishna R.¹,Low Philip S.¹

Affiliation:

1. Department of Chemistry, Purdue University, 560 Oval Drive, West Lafayette, Indiana 47907, and Endocyte, Inc., 3000 Kent Avenue, West Lafayette, Indiana 47906

Publisher

American Chemical Society (ACS)

Subject

Drug Discovery,Pharmaceutical Science,Molecular Medicine

Link

https://pubs.acs.org/doi/pdf/10.1021/mp900069d

Reference47 articles.

1. Cancer Statistics, 2008

2. Cumulative cost pattern comparison of prostate cancer treatments

3. Quality of Life for Men With Prostate Cancer

4. Grading of Prostate Cancer

5. Assessment of Screening for Prostate Cancer Using the Digital Rectal Examination

Cited by 168 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Selective targeting of chemically modified miR-34a to prostate cancer using a small molecule ligand and an endosomal escape agent;Molecular Therapy - Nucleic Acids;2024-06

2. Synthesis and Preclinical Evaluation of Urea-Based Prostate-Specific Membrane Antigen-Targeted Conjugates Labeled with ¹⁷⁷Lu;ACS Pharmacology & Translational Science;2024-05-01

3. Mono-amino acid linkers enable highly potent small molecule-drug conjugates by conditional release;Molecular Therapy;2024-04

4. Transforming toxins into treatments: the revolutionary role of α-amanitin in cancer therapy;Archives of Toxicology;2024-03-30

5. Developing Folate-Conjugated miR-34a Therapeutic for Prostate Cancer: Challenges and Promises;International Journal of Molecular Sciences;2024-02-09